Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease

Blood (2024) 143 (1): 21–31.

https://doi.org/10.1182/blood.2023020250

Published: 2024

Includes: Supplemental data

Journal Articles

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study

Mary Mansour Riwes, Jonathan Louis Golob, John M. Magenau, Costas Lyssiotis, Mengrou Shan, Gregory Dick, Thomas Braun, Thomas M Schmidt, Attaphol Pawarode, Sarah Anand, Monalisa Ghosh, John Maciejewski, Darren King, Sung W. Choi, Gregory Yanik, Marcus Johannes Geer, Ethan Hillman, Muneesh Tewari, Pavan Reddy

Blood (2023) 142 (Supplement 1): 2190.

https://doi.org/10.1182/blood-2023-181260

Published: 2023

Journal Articles

Pneumocystis Jirovecii Infection in Autologous Hematopoietic Stem Cell Transplant Recipients

John E Coda, Kadee Raser, Sarah M. Anand, Monalisa Ghosh, John Maciejewski, Attaphol Pawarode, Mary Mansour Riwes, Christina Tillman, Gregory Yanik, John M. Magenau, Matthew J. Pianko

Blood (2021) 138 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2021-144633

Published: 2021

Journal Articles

Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)

Michael Scordo, MD, Lihua E Budde, MD PhD, Mehrdad Abedi, MD, Carolyn Mulroney, MD, Bita Fakhri, MDMPH, Attaphol Pawarode, MDPhD, Bhagirathbhai Dholaria, MBBS, Edward Kavalerchik, MD, Sanjay K. Aggarwal, MD, Muzaffar H. Qazilbash, MD, Paul Finnegan, MD, Sergio A. Giralt, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137257

Published: 2020

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

Blood (2018) 131 (25): 2846–2855.

https://doi.org/10.1182/blood-2018-01-822957

Published: 2018

Includes: Supplemental data

Journal Articles

α 1 -Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease

John M. Magenau, Steven C. Goldstein, Dan Peltier, Robert J. Soiffer, Thomas Braun, Attaphol Pawarode, Mary M. Riwes, Maggi Kennel, Joseph H. Antin, Corey S. Cutler, Vincent T. Ho, Edwin P. Alyea, III, Brian L. Parkin, Gregory A. Yanik, Sung Won Choi, Eli C. Lewis, Charles A. Dinarello, John Koreth, Pavan Reddy

Blood (2018) 131 (12): 1372–1379.

https://doi.org/10.1182/blood-2017-11-815746

Published: 2018

Includes: Supplemental data

Journal Articles

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Attaphol Pawarode, MD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Bryon Johnson, PhD, Thomas Braun, PhD, Binod Dhakal, MBBS, Mehdi Hamadani, MD, John M. Magenau, MD, Nirav N Shah, MD, Mary Mansour Riwes, DO, Brian Parkin, MD, Pavan Reddy, MD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 339.

https://doi.org/10.1182/blood.V130.Suppl_1.339.339

Published: 2017

Journal Articles

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Sung Won Choi, Thomas Braun, Israel Henig, Erin Gatza, John Magenau, Brian Parkin, Attaphol Pawarode, Mary Riwes, Greg Yanik, Charles A. Dinarello, Pavan Reddy

Blood (2017) 130 (15): 1760–1767.

https://doi.org/10.1182/blood-2017-06-790469

Published: 2017

Journal Articles

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Blood (2017) 130 (9): 1156–1164.

https://doi.org/10.1182/blood-2017-03-772368

Published: 2017

Includes: Supplemental data

Journal Articles

An Early Biomarker Algorithm Predicts Lethal Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation

Blood (2016) 128 (22): 509.

https://doi.org/10.1182/blood.V128.22.509.509

Published: 2016

Journal Articles

Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment

Blood (2016) 128 (22): 510.

https://doi.org/10.1182/blood.V128.22.510.510

Published: 2016

Journal Articles

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode, MD, Steven Goldstein, MD, Daniel R. Couriel, MD, Thomas Braun, PhD, John M. Magenau, MD, Mary Mansour Riwes, DO, Brian Parkin, Vedran Radojcic, MD, David Frame, PharmD, Sung Choi, MD, James Connelly, MD, John E. Levine, MD MS, Gregory A. Yanik, MD, Pavan Reddy, MD

Blood (2015) 126 (23): 1907.

https://doi.org/10.1182/blood.V126.23.1907.1907

Published: 2015

Journal Articles

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Rima M Saliba, PhD, Carrie Kitko, MD, Pavan Reddy, MD, John M. Magenau, MD, Attaphol Pawarode, Steven Goldstein, Daniel R. Couriel, MD

Blood (2014) 124 (21): 5875.

https://doi.org/10.1182/blood.V124.21.5875.5875

Published: 2014

Journal Articles

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

Kadee J Raser, M.S., PA-C, Gregory A. Yanik, MD, John M. Magenau, M.D., Steven C. Goldstein, MD, Attaphol Pawarode, Carrie Kitko, M.D., John E. Levine, M.D., M.S., David Hanauer, M.S., M.D., Daniel R. Couriel, MD

Blood (2013) 122 (21): 3372.

https://doi.org/10.1182/blood.V122.21.3372.3372

Published: 2013

Journal Articles

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

Sameem Abedin, MD, Gregory A. Yanik, MD, John M. Magenau, MD, Steven C. Goldstein, MD, Attaphol Pawarode, MD, John E. Levine, M.D., M.S., Carrie L. Kitko, MD, Daniel R. Couriel, MD

Blood (2013) 122 (21): 2060.

https://doi.org/10.1182/blood.V122.21.2060.2060

Published: 2013

Journal Articles

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

Gregory A. Yanik, John M. Magenau, Shin Mineishi, Attaphol Pawarode, Keith Alangaden, Edward M. Peres, Steven Goldstein, John E. Levine, Sung Choi, Carrie L Kitko, Moshe Talpaz, MD, Daniel Couriel

Blood (2012) 120 (21): 3119.

https://doi.org/10.1182/blood.V120.21.3119.3119

Published: 2012

Journal Articles

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Thomas M. Braun, Ph.D., Daniel R. Couriel, M.D., Sung W. Choi, M.D., Carrie Kitko, M.D., Steven Goldstein, John M. Magenau, M.D., Sophie Paczesny, M.D., Ph.D, Attaphol Pawarode, Pavan Reddy, M.D., Gregory A. Yanik, Austin Taylor, James Connelly, M.D., Craig A. Byersdorfer, M.D., Ph.D., John E. Levine, M.D., M.S.

Blood (2012) 120 (21): 463.

https://doi.org/10.1182/blood.V120.21.463.463

Published: 2012

Journal Articles

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Blood (2012) 120 (21): 740.

https://doi.org/10.1182/blood.V120.21.740.740

Published: 2012

Journal Articles

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

Blood (2011) 118 (15): 4258–4264.

https://doi.org/10.1182/blood-2011-06-358010

Published: 2011

Includes: Supplemental data

NARROW

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study

Pneumocystis Jirovecii Infection in Autologous Hematopoietic Stem Cell Transplant Recipients

Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

α 1 -Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

An Early Biomarker Algorithm Predicts Lethal Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation

Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only